18F-GE-180 provided higher sensitivity to detect microglial activation and its changes under therapy in a mouse model of Alzheimer’s disease compared to the second-generation TSPO tracer 18F-PBR06 [19]. This evidence concerns the gene TSPO and Alzheimer disease.